Home › Multiple Myeloma › Arkansas › Springdale
Multiple Myeloma clinical trials in Springdale, AR
3 studies for Multiple Myeloma are looking for participants at sites in and around Springdale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 3
- Highlands Oncology Group, Springdale
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
RecruitingPhase 1
- Highlands Oncology Group, PA, Springdale
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 1
- Highlands Oncology Group - Springdale /ID# 267742, Springdale
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO27 studies
- Rochester, MN24 studies
- St. Louis, MO24 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- Chicago, IL22 studies
Other studies in Springdale
- Non-Small Cell Lung Cancer15 studies
- Schizophrenia7 studies
- Lung Cancer6 studies
- Metastatic Cancer6 studies
- Breast Cancer5 studies
- Cancer (all types)5 studies
- Major Depressive Disorder5 studies
- Colorectal Cancer5 studies
- Depression4 studies
- Bladder Cancer4 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Small Cell Lung Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.